Interactome map reveals phospholipid scramblase 1 as a novel regulator of hepatitis B virus x protein.

HBV X protein plays crucial roles during viral infection and hepatocellular carcinoma (HCC) development through interaction with various host factors. Here, we mapped the interactome of HBx using a yeast two-hybrid screen. Nine human proteins were identified as novel interacting partners of HBx, one of which is phospholipid scramblase 1 (PLSCR1). PLSCR1 is an interferon-inducible protein that mediates antiviral activity against DNA and RNA viruses. However, the molecular mechanisms of PLSCR1 activity against HBV remain unclear. Here, we reported that PLSCR1 promotes HBx degradation by a proteasome- and ubiquitin-dependent mechanism. Furthermore, we found that PLSCR1 inhibits HBx-mediated cell proliferation. After HBV infection, the protein level of PLSCR1 in plasma is elevated, and chronic hepatitis B patients with low plasma levels of PLSCR1 have a high risk of developing HCC. These results suggest that the nuclear trafficking of PLSCR1 mediates the antiviral activity and anticarcinogenesis against HBV by regulating HBx stability.

[1]  E. Azhar,et al.  Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. , 2014, World journal of gastroenterology.

[2]  C. Weghorst,et al.  Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors. , 2014, Anticancer research.

[3]  M. Brunetto,et al.  Interferon Therapy of Chronic Hepatitis B , 2014, Intervirology.

[4]  Junqiao Zhu,et al.  Phospholipid Scramblase 1 Functionally Interacts with Angiogenin and Regulates Angiogenin-Enhanced rRNA Transcription , 2013, Cellular Physiology and Biochemistry.

[5]  Yuquan Wei,et al.  Unraveling the complexity of hepatitis B virus: from molecular understanding to therapeutic strategy in 50 years. , 2013, The international journal of biochemistry & cell biology.

[6]  Howard L McLeod,et al.  Exome Resequencing Identifies Potential Tumor‐Suppressor Genes that Predispose to Colorectal Cancer , 2013, Human mutation.

[7]  Zhong-yu Wang,et al.  Hepatitis B virus X protein in the proliferation of hepatocellular carcinoma cells. , 2013, Frontiers in bioscience.

[8]  Hui Hui,et al.  Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cells. , 2013, Blood.

[9]  Y. Eizuru,et al.  Interaction of the phospholipid scramblase 1 with HIV-1 Tat results in the repression of Tat-dependent transcription. , 2013, Biochemical and biophysical research communications.

[10]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[11]  N. Krogan,et al.  CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. , 2013, Molecular cell.

[12]  F. He,et al.  Hepatitis B virus encoded X protein suppresses apoptosis by inhibition of the caspase-independent pathway. , 2012, Journal of proteome research.

[13]  P. An,et al.  Silencing phospholipid scramblase 1 expression by RNA interference in colorectal cancer and metastatic liver cancer. , 2012, Hepatobiliary & pancreatic diseases international : HBPD INT.

[14]  Jing Yang,et al.  Inhibition of Hepatitis B virus replication by phospholipid scramblase 1 in vitro and in vivo. , 2012, Antiviral research.

[15]  L. Xian,et al.  E3 ubiquitin ligase Siah‐1 facilitates poly‐ubiquitylation and proteasomal degradation of the hepatitis B viral X protein , 2011, FEBS letters.

[16]  F. He,et al.  Phospholipid scramblase 1 mediates hepatitis C virus entry into host cells , 2011, FEBS letters.

[17]  Yun-Fai Chris Lau,et al.  The X-Linked Tumor Suppressor TSPX Interacts and Promotes Degradation of the Hepatitis B Viral Protein HBx via the Proteasome Pathway , 2011, PloS one.

[18]  C. Lee,et al.  Hepatitis B virus X gene and hepatocarcinogenesis , 2011, Journal of Gastroenterology.

[19]  M. Kew.  Hepatitis B virus x protein in the pathogenesis of hepatitis B virus‐induced hepatocellular carcinoma , 2011, Journal of gastroenterology and hepatology.

[20]  B. Bartosch.  Hepatitis B and C Viruses and Hepatocellular Carcinoma , 2010, Viruses.

[21]  Jing Zhao,et al.  p53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2 , 2010, Molecular Biology Reports.

[22]  M. Wolter,et al.  Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas , 2010, International journal of cancer.

[23]  Zhenghong Yuan,et al.  Inhibition of Hepatitis B Virus Replication by MyD88 Involves Accelerated Degradation of Pregenomic RNA and Nuclear Retention of Pre-S/S RNAs , 2010, Journal of Virology.

[24]  M. Buendia,et al.  Mechanisms of HBV-related hepatocarcinogenesis. , 2010, Journal of hepatology.

[25]  M. Mathews,et al.  Progranulin (granulin/epithelin precursor) and its constituent granulin repeats repress transcription from cellular promoters , 2010, Journal of cellular physiology.

[26]  M. Dandri,et al.  The replication cycle of hepatitis B virus. , 2010, Journal of hepatology.

[27]  S. Benichou,et al.  The Phospholipid Scramblases 1 and 4 Are Cellular Receptors for the Secretory Leukocyte Protease Inhibitor and Interact with CD4 at the Plasma Membrane , 2009, PloS one.

[28]  Seung-Woo Hong,et al.  p34SEI-1 inhibits apoptosis through the stabilization of the X-linked inhibitor of apoptosis protein: p34SEI-1 as a novel target for anti-breast cancer strategies. , 2009, Cancer research.

[29]  I. Screpanti,et al.  Notch3: from subtle structural differences to functional diversity , 2008, Oncogene.

[30]  K. Feingold,et al.  Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response. , 2007, Biochimica et biophysica acta.

[31]  S. Gummadi,et al.  Phospholipid scramblases: an overview. , 2007, Archives of biochemistry and biophysics.

[32]  G. Guy,et al.  Sprouty and cancer: the first terms report. , 2006, Cancer letters.

[33]  Joonhee Kim,et al.  Negative regulation of hepatitis B virus replication by cellular Hsp40/DnaJ proteins through destabilization of viral core and X proteins. , 2006, The Journal of general virology.

[34]  P. Sims,et al.  Phospholipid Scramblase 1 Binds to the Promoter Region of the Inositol 1,4,5-Triphosphate Receptor Type 1 Gene to Enhance Its Expression* , 2005, Journal of Biological Chemistry.

[35]  G. Cingolani,et al.  Phospholipid Scramblase 1 Contains a Nonclassical Nuclear Localization Signal with Unique Binding Site in Importin α* , 2005, Journal of Biological Chemistry.

[36]  M. Bouchard,et al.  The Enigmatic X Gene of Hepatitis B Virus , 2004, Journal of Virology.

[37]  R. N. Harty,et al.  Phospholipid Scramblase 1 Potentiates the Antiviral Activity of Interferon , 2004, Journal of Virology.

[38]  L. Gerace,et al.  Phospholipid scramblase 1 is imported into the nucleus by a receptor-mediated pathway and interacts with DNA. , 2004, Biochemistry.

[39]  H. Bernard,et al.  The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1. , 2003, Virology.

[40]  P. Sims,et al.  Palmitoylation of phospholipid scramblase 1 controls its distribution between nucleus and plasma membrane. , 2003, Biochemistry.

[41]  R. Silverman,et al.  Suppression of ovarian carcinoma cell growth in vivo by the interferon-inducible plasma membrane protein, phospholipid scramblase 1. , 2002, Cancer research.

[42]  C. McArthur,et al.  Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53. , 2001, Archives of oral biology.

[43]  P. Sims,et al.  Identification of three new members of the phospholipid scramblase gene family. , 2000, Biochimica et biophysica acta.

[44]  A. Goldberg,et al.  Hepatitis B Virus X Protein Is both a Substrate and a Potential Inhibitor of the Proteasome Complex , 1999, Journal of Virology.

[45]  D. Montefiori,et al.  Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Alavian,et al.  Hepatitis B virus-induced hepatocellular carcinoma: the role of the virus x protein. , 2013, Acta virologica.

[47]  E. Swisher.  Granulin: biomarker or interesting window into host/tumor biology? , 2011, Gynecologic oncology.

[48]  Yu-Sun Chang,et al.  Identification of Phospholipid Scramblase 1 as a Biomarker and Determination of Its Prognostic Value for Colorectal Cancer , 2011, Molecular medicine.